Parkinson's Disease Clinical Trials in Chicago, Illinois

5 studies are recruiting for parkinson's disease in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

   The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease. The utilization of Image Guided Programming (IGP), and other commercially available programming fea…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Rush University Medical Center, Chicago, Illinois

   Locations

   86 in total

   Run by

   Boston Scientific Corporation

   See if you can join NCT02071134 on ClinicalTrials.gov

2. Parkinson's Foundation PD GENEration Genetic Registry

   Development of a central repository for PD-related genomic data for future research.

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Illinois-Chicago, Chicago, Illinois

   Locations

   70 in total

   Run by

   Parkinson's Foundation

   See if you can join NCT04994015 on ClinicalTrials.gov

3. A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

   The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of prasinezumab compared with placebo in participants with early-stage Parkinson's disease (PD) on stable symptomatic monotherapy with levodopa.

   Stage

   Phase 3

   Ages

   50 to 85

   Site

   Northwestern University Feinberg School Of Medicine, Chicago, Illinois

   Locations

   192 in total

   Run by

   Hoffmann-La Roche

   See if you can join NCT07174310 on ClinicalTrials.gov

4. A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

   The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics/pharmacodynamics (PK/PD) of LY3962681 in healthy volunteers and patients with Parkinson's disease. The study consists of two parts, the Single Ascending Dose (SAD) study and the Multiple Ascending Dose (MAD) stu…

   Stage

   Phase 1

   Ages

   30 to 80

   Site

   Northwestern University Feinberg School of Medicine Dept of Neurology, Chicago, Illinois

   Locations

   16 in total

   Run by

   Prevail Therapeutics

   See if you can join NCT06565195 on ClinicalTrials.gov

5. rTMS to Improve Cognition in Parkinson's

   The purpose of this study is to examine safety, feasibility, and the behavioral and brain effects of a non-invasive treatment, repetitive transcranial magnetic stimulation (rTMS), for Veterans with Parkinson's disease or atypical parkinsonism and mild impairments in their thinking. The hypothesis i…

   Stage

   Phase 1

   Ages

   50 and older

   Site

   Jesse Brown VA Medical Center, Chicago, IL, Chicago, Illinois

   Locations

   2 in total

   Run by

   VA Office of Research and Development

   See if you can join NCT03836950 on ClinicalTrials.gov